Full history for every metric is available with a Kvantra account
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 751 | 709 | 736 | 713 | 738 | 598 | 607 | 611 |
| Operating profit | $m | 109 | 121 | ||||||
| Net profit | $m | -67.0 | 2.5 | -51.1 | 26.5 | -47.8 | 62.3 | 73.7 | 89.5 |
| EPS reported | $ | -0.08 | 0.13 | ||||||
| Operating cashflow per share | $ | 0.13 | 0.11 | ||||||
| Capex per share | $ | 0.04 | 0.05 | ||||||
| FCF per share | $ | 0.09 | 0.07 | ||||||
| Free cash flow | $m | 54.0 | 38.0 | ||||||
| Net debt | $m | 182 | 160 | ||||||
| Book value equity | $m | 644 | 663 | ||||||
| Book value per share | $ | 1.10 | 1.14 | ||||||
| Number of shares | m | 583.6 | 579.6 | ||||||
| DPS (TTM paid) | $ | 0.04 | 0.05 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 2.02 | 2.07 | ||||||
| P/S LTM | x | 2.18 | 2.26 | ||||||
| P/FCF LTM | x | 24.13 | 36.10 | ||||||
| EV/EBITDA LTM | x | 10.75 | 9.45 | ||||||
| EV/Sales LTM | x | 2.52 | 2.53 | ||||||
| Earnings Yield LTM | % | 4.78% | 5.39% | ||||||
| FCF Yield | % | 4.14% | 2.77% | ||||||
| Quality | |||||||||
| ROE | % | 9.67% | 11.29% | ||||||
| ROIC | % | 7.51% | 8.29% | ||||||
| Operating margin | % | 18.24% | 19.92% | ||||||
| Gross margin | % | 46.88% | 48.57% | ||||||
| FCF/Sales | % | 9.04% | 6.27% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | +219.41% | ||||||
| Sales Growth YoY | % | -19.07% | -8.59% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | -13.17% | -44.06% | ||||||
| Operating Profit Growth | % | - | +190.40% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 1.98% | 1.88% | ||||||
| Dividend Growth | % | +293.32% | - | ||||||
| Payout Ratio | % | -56.75% | 41.46% | ||||||
| FCF/Debt | x | 0.21 | 0.14 | ||||||
| Net Debt/EBITDA | x | 1.44 | 1.10 | ||||||
| EBIT/Net interest | x | 5.59 | 7.20 | ||||||
| Net debt/market cap | % | 13.94% | 11.68% | ||||||
| Net debt/Equity | x | 0.28 | 0.24 | ||||||
| Gross debt/equity | x | 0.40 | 0.40 | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Elementis plc operates as a specialty chemical company in the United Kingdom, rest of Europe, North America, and internationally. It operates in two segments, Coatings and Personal Care. The Coatings segment offers production of rheological modifiers and additives for decorative and industrial coatings; and performance chemicals for the energy sector. This segment provides products for applications in architectural and industrial coatings, adhesives, and sealants and construction additives. The Personal Care segment offers rheological modifiers and compounded products, including active ingredients for antiperspirants (AP) deodorants for personal care manufacturers. This segment offers products for applications in antiperspirants, skin care, and color cosmetics. Elementis plc was founded in 1844 and is headquartered in London, the United Kingdom.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Based on consensus from external analysts. Not Kvantra's opinion.
Elementis plc operates as a specialty chemical company in the United Kingdom, rest of Europe, North America, and internationally. It operates in two segments, Coatings and Personal Care. The Coatings segment offers production of rheological modifiers and additives for decorative and industrial coatings; and performance chemicals for the energy sector. This segment provides products for applications in architectural and industrial coatings, adhesives, and sealants and construction additives. The Personal Care segment offers rheological modifiers and compounded products, including active ingredients for antiperspirants (AP) deodorants for personal care manufacturers. This segment offers products for applications in antiperspirants, skin care, and color cosmetics. Elementis plc was founded in 1844 and is headquartered in London, the United Kingdom.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free